Rafferty Asset Management, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,951,245
+6.9%
241,642
+3.7%
0.03%
+11.5%
Q2 2023$4,631,379
-9.7%
233,084
-22.2%
0.03%
-25.7%
Q1 2023$5,129,733
-10.8%
299,459
+1.9%
0.04%
-27.1%
Q4 2022$5,752,817
+59.1%
293,961
+29.8%
0.05%
+26.3%
Q3 2022$3,615,000
+203.3%
226,518
+161.5%
0.04%
+245.5%
Q2 2022$1,192,000
-54.5%
86,622
-47.6%
0.01%
-31.2%
Q1 2022$2,621,000
-16.8%
165,273
+14.4%
0.02%
-5.9%
Q4 2021$3,152,000
+19.6%
144,407
+63.7%
0.02%
-5.6%
Q3 2021$2,636,000
+5.4%
88,194
+56.1%
0.02%
+12.5%
Q2 2021$2,502,000
-9.2%
56,487
-9.1%
0.02%
-15.8%
Q1 2021$2,757,000
+621.7%
62,133
+791.4%
0.02%
+375.0%
Q4 2020$382,000
-54.6%
6,970
-81.1%
0.00%
-60.0%
Q3 2020$842,000
+170.7%
36,822
+148.0%
0.01%
+150.0%
Q2 2020$311,000
-13.4%
14,847
-5.9%
0.00%
-33.3%
Q4 2019$359,000
-24.7%
15,783
-61.5%
0.01%
-14.3%
Q3 2019$477,000
-28.9%
40,981
-8.4%
0.01%
-41.7%
Q2 2019$671,000
+23.8%
44,715
+44.6%
0.01%
+33.3%
Q1 2019$542,00030,9230.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders